CIK 0000310158
- Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221918501
- Phone
- +1 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,611,875
- in 1 filing
Net −$8,611,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-27 | Warden Kathy J Director | Grant or award · Phantom Stock | +2,363.56 | $93.08 | $220K | 8,018.03 |
| 2022-05-27 | Thulin Inge G Director | Grant or award · Phantom Stock | +2,363.56 | $93.08 | $220K | 16,518.63 |
| 2022-05-27 | Seidman Christine E Director | Grant or award · Phantom Stock | +2,363.56 | $93.08 | $220K | 9,782.79 |
| 2022-05-27 | RUSSO PATRICIA F Director | Grant or award · Phantom Stock | +2,363.56 | $93.08 | $220K | 47,506.93 |
| 2022-05-27 | Rothman Paul Director | Grant or award · Phantom Stock | +2,363.56 | $93.08 | $220K | 23,152.02 |
| 2022-05-27 | Mayo Stephen Director | Grant or award · Phantom Stock | +2,363.56 | $93.08 | $220K | 5,297.52 |
| 2022-05-27 | LAVIZZO-MOUREY RISA J Director | Grant or award · Phantom Stock | +2,363.56 | $93.08 | $220K | 7,892.96 |
| 2022-05-27 | GLOCER THOMAS H Director | Grant or award · Phantom Stock | +2,363.56 | $93.08 | $220K | 83,715.81 |
| 2022-05-27 | Craig Pamela J. Director | Grant or award · Phantom Stock | +2,363.56 | $93.08 | $220K | 23,152 |
| 2022-05-27 | Coe Mary Ellen Director | Grant or award · Phantom Stock | +2,363.56 | $93.08 | $220K | 15,811.28 |
| 2022-05-27 | BAKER DOUGLAS M JR Director | Grant or award · Phantom Stock | +2,363.56 | $93.08 | $220K | 2,363.56 |
| 2022-05-04 | Oosthuizen Johannes Jacobus SVP, U.S. Market | Option exercise | +907 | $87.10 | $79K | 14,960.88 |
| 2022-05-04 | Oosthuizen Johannes Jacobus SVP, U.S. Market | Shares withheld for taxes | −447 | $87.10 | $39K | 14,513.88 |
| 2022-05-04 | Oosthuizen Johannes Jacobus SVP, U.S. Market | Option exercise · Restricted Stock Unit | −907 | 1,819 | ||
| 2022-05-04 | Garay Arpa SVP Human Health Global Mktg. | Option exercise | +907 | $87.10 | $79K | 2,368 |
| 2022-05-04 | Garay Arpa SVP Human Health Global Mktg. | Shares withheld for taxes | −259 | $87.10 | $23K | 2,109 |
| 2022-05-04 | Garay Arpa SVP Human Health Global Mktg. | Option exercise · Restricted Stock Unit | −907 | 1,819 | ||
| 2022-05-04 | Karachun Rita A Sr. VP Fince-Global Controller | Option exercise | +949 | $87.10 | $83K | 41,428.97 |
| 2022-05-04 | Karachun Rita A Sr. VP Fince-Global Controller | Shares withheld for taxes | −326 | $87.10 | $28K | 41,102.97 |
| 2022-05-04 | Karachun Rita A Sr. VP Fince-Global Controller | Option exercise · Restricted Stock Unit | −949 | 1,900 |
Page 34 of 42 · 823 trades